Abstract
INTRODUCTION: Prucalopride is a selective, high-affinity agonist of the 5-hydroxytryptamine-4 (5-HT4) receptor and is indicated for the treatment of adult patients with chronic constipation. In humans, prucalopride is rapidly absorbed and extensively distributed, reaching maximum plasma concentration 2–3 h after a 2 mg oral dose. We report three studies investigating tissue distribution of prucalopride in rats. METHODS: A single oral dose of 14C-labelled prucalopride at 5mg base-equivalent(eq)/kg was administered to 30 SPF Wistar rats (5 males, seven groups of 3 non-pregnant females and 4 pregnant females [dose administered on day 18 of gestation]). Total radioactivity (TR) in various tissues was measured up to 96h. In females, the area under the TR concentration curve for up to 8h (AUC0–8h) and the AUC0–8h tissue:plasma ratio was calculated. The tissue concentration of unchanged drug (UD) was measured up to 48 h. RESULTS: The highest mean TR for all rats was detected in the pancreas (8.9µg-eq/g within 30 min of dosing; below the limit of detection [LOD] after 24 h), the liver (12.5 µg-eq/g within 20 min; 0.3 µg-eq/g after 96 h) and the small intestine (15.6µg-eq/g within 30 min; below the LOD after 24 h). The highest mean concentration of UD in non-pregnant females was detected in the small intestine (10.1 µg-eq/g within 20 min; below the LOD after 24 h). The lowest mean TR was detected in the brain, in males (0.12 µg-eq/g within 30 min), non-pregnant females (0.21 µg-eq/g within 1 h) and pregnant females (0.21 µg-eq/g within 30 min). TR in the brain was below the LOD within 2, 24 and 8 h of dosing, respectively. In non-pregnant females, the highest AUC0–8h and AUC0–8h tissue:plasma ratios of TR were observed in the small intestine (75.3 and 31.3, respectively); the lowest values were observed in the brain (0.85 and 0.35, respectively). Findings were similar for UD. In pregnant females the highest AUC0–8h and AUC0–8h tissue:plasma ratios of TR were observed in rectal (mucosa) and salivary gland tissue (122 and 20.5, respectively, for both); the lowest values were observed in the brain (0.33 and 0.17 [AUC0–2h], respectively). CONCLUSION: After a single oral dose of prucalopride, high concentrations were detected in the pancreas, liver and small intestine, and very low concentrations in the brain (∼0.05% of the dose in non-pregnant female rats). Mean concentrations of TR and UD in the brain were below the LOD within 24h of dosing, suggesting prucalopride is not unduly retained in the brain.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.